T Tourmaline Bio, Inc.: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of Tourmaline Bio, Inc., a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 28 October 2025 (U). Among the most active insiders: Kulkarni Sandeep Chidambar. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 28 October 2025
All Executives21 Thresholds0 Prospectus0 Other0
Declarations 21 total
● Director · Executives · 28 Oct 2025
515,997 shares Common Stock SEC:0001355758-25-000006:0
● Director · Executives · 28 Oct 2025
431,939 shares Common Stock SEC:0001355758-25-000006:1
▲ CEO · Executives · 21 Aug 2024
1,779 shares @ US$14.85 11.9% of flow Common Stock SEC:0001827506-24-000076:0
Ideal exit: 18 May 2025 (T+270) ▲ CEO · Executives · 16 Aug 2024
5,221 shares @ US$13.79 33.0% of flow Common Stock SEC:0001827506-24-000074:0
Ideal exit: 13 May 2025 (T+270) ▲ Director · Executives · 29 Jan 2024
100,000 shares @ US$32.50 100.0% of flow Common Stock SEC:0001415889-24-002069:0
Ideal exit: 25 Oct 2024 (T+270) ▲ CEO · Executives · 17 Nov 2023
4,000 shares @ US$16.99 31.5% of flow Common Stock SEC:0001209191-23-056128:0
Ideal exit: 13 Aug 2024 (T+270) ▲ Director · Executives · 17 Nov 2023
1,000 shares @ US$17.31 24.1% of flow Common Stock SEC:0001209191-23-056126:0
Ideal exit: 13 Aug 2024 (T+270) ▲ Director · Executives · 25 Oct 2023
4,200 shares @ US$12.07 100.0% of flow Common Stock SEC:0001209191-23-053791:0
Ideal exit: 21 Jul 2024 (T+270) ▲ Director · Executives · 24 Oct 2023
5,000 shares @ US$10.66 75.9% of flow Common Stock SEC:0001209191-23-053670:0
Ideal exit: 20 Jul 2024 (T+270) ▲ CEO · Executives · 24 Oct 2023
4,650 shares @ US$10.68 23.6% of flow Common Stock SEC:0001209191-23-053691:0
Ideal exit: 20 Jul 2024 (T+270) ▲ Director · Executives · 24 Oct 2023
7,500 shares @ US$11.86 100.0% of flow Common Stock SEC:0001209191-23-053674:0
Ideal exit: 20 Jul 2024 (T+270) ◆ Director · Executives · 19 Oct 2023
496,519 shares Common Stock SEC:0001209191-23-053389:0
◆ CBO, GC and Secretary · Executives · 19 Oct 2023
69,201 shares Common Stock SEC:0001209191-23-053403:0
◆ CEO · Executives · 19 Oct 2023
716,085 shares Common Stock SEC:0001209191-23-053399:0
◆ Chief Technology Officer · Executives · 19 Oct 2023
22,934 shares Common Stock SEC:0001209191-23-053395:0
◆ Director · Executives · 19 Oct 2023
37,891 shares Common Stock SEC:0001209191-23-053397:0
◆ Chief Regulatory Officer · Executives · 19 Oct 2023
57,834 shares Common Stock SEC:0001209191-23-053393:0
◆ Director · Executives · 19 Oct 2023
348,431 shares Common Stock SEC:0001209191-23-053401:0
◆ Chief Medical Officer · Executives · 19 Oct 2023
56,836 shares Common Stock SEC:0001209191-23-053391:0
◆ Director · Executives · 19 Oct 2023
75,782 shares Common Stock SEC:0001209191-23-053409:0
◆ Director · Executives · 19 Oct 2023
518 shares Common Stock SEC:0001209191-23-053407:0